Open AccessEfficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents
Author(s) -
Juan C. Salazar,
Pedro Cahn,
Ram Yogev,
Marinella Della Negra,
Guido Castelli Gattinara,
Clàudia Fortuny,
Patrica M Flynn,
Carlo Giaquinto,
Ping Ruan,
Mary E. Smith,
Jaromir Mikl,
Ante Jelaska
Publication year - 2008
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32830c481b
Subject(s) - tolerability , medicine , ritonavir , regimen , adverse effect , viral load , vomiting , gastroenterology , randomized controlled trial , protease inhibitor (pharmacology) , diarrhea , pharmacology , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy
To evaluate the efficacy, safety and tolerability of ritonavir-boosted tipranavir (TPV/r) in HIV-1-infected pediatric patients.